Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)

3 clinical trials · Condition

Record	Firm	Date
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism (NCT03139487)	Asan Medical Center	2017-08-07

Every clearance here is in the API, with alerts when new ones post.